Abstract | AIM: METHODS: Over a 2-year period, 26 patients with bipolar I disorder (manic episode) and 56 healthy controls were recruited. The Young Mania Rating Scale scores of patients with bipolar mania were >26. Serum BDNF and TrkB protein levels were measured with ELISA kits. RESULTS: Using ANCOVA with age adjustment, we found that there were no significant differences in serum BDNF protein levels between patients with bipolar mania and healthy controls (p = 0.582). In contrast, the serum TrkB protein level was significantly higher in bipolar mania patients than in healthy controls (p = 0.001), especially in women (p = 0.001). Of 26 patients with bipolar mania, 21 underwent a second measurement of serum BDNF and TrkB protein levels after a 4-week treatment with mood stabilizers. There were no significant changes in serum BDNF or TrkB protein levels. CONCLUSION: These findings suggest that serum TrkB protein levels may play an important role in the psychopathology of bipolar mania. However, a larger sample size is needed to confirm these results.
|
Authors | Tiao-Lai Huang, Yi-Yung Hung, Chien-Te Lee, Rong-Fu Chen |
Journal | Neuropsychobiology
(Neuropsychobiology)
Vol. 65
Issue 2
Pg. 65-9
( 2012)
ISSN: 1423-0224 [Electronic] Switzerland |
PMID | 22222435
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 S. Karger AG, Basel. |
Chemical References |
- Antimanic Agents
- Brain-Derived Neurotrophic Factor
- Valproic Acid
- Protein Kinases
- tropomyosin kinase
- Lithium Chloride
|
Topics |
- Adult
- Analysis of Variance
- Antimanic Agents
(therapeutic use)
- Bipolar Disorder
(blood, drug therapy)
- Brain-Derived Neurotrophic Factor
(blood)
- Female
- Humans
- Lithium Chloride
(therapeutic use)
- Male
- Middle Aged
- Protein Kinases
(blood)
- Retrospective Studies
- Valproic Acid
(therapeutic use)
- Young Adult
|